Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


22.02.2021

1 Ann Thorac Surg
1 Cardiovasc Res
1 Circ Res
1 Circulation
1 Eur Heart J
8 Eur J Heart Fail
1 Heart
5 Int J Cardiol
1 J Am Coll Cardiol
9 J Card Fail
1 J Cardiol
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Thorac Surg

  1. WILSON HK, Haithcock BE, Caranasos TG
    Novel Modification of HeartMate 3 Implantation.
    Ann Thorac Surg. 2021;111:e133-e134.
    PubMed         Abstract available


    Cardiovasc Res

  2. TERAMOTO K, Tromp J, Lam CSP
    Heart failure or heart success?
    Cardiovasc Res. 2021 Feb 13. pii: 6134544. doi: 10.1093.
    PubMed        


    Circ Res

  3. MUSTROPH J, Sag CM, Bahr F, Schmidtmann AL, et al
    Loss of CASK Accelerates Heart Failure Development.
    Circ Res. 2021 Feb 17. doi: 10.1161/CIRCRESAHA.120.318170.
    PubMed         Abstract available


    Circulation

  4. UMAPATHI P, Banerjee PS, Zachara NE, Abrol N, et al
    Excessive O - GlcNAcylation Causes Heart Failure and Sudden Death.
    Circulation. 2021 Feb 17. doi: 10.1161/CIRCULATIONAHA.120.051911.
    PubMed         Abstract available


    Eur Heart J

  5. VILLRINGER A, Laufs U
    Heart failure, cognition, and brain damage.
    Eur Heart J. 2021 Feb 16. pii: 6139887. doi: 10.1093.
    PubMed        


    Eur J Heart Fail

  6. TOMASONI D, Adamo M, Metra M
    December 2020 at a glance: focus on COVID-19, comorbidities and palliative care.
    Eur J Heart Fail. 2020;22:2173-2174.
    PubMed        

  7. ALHAKAK AS, Teerlink JR, Lindenfeld J, Bohm M, et al
    The Significance of Left Ventricular Ejection Time in Heart Failure with Reduced Ejection Fraction.
    Eur J Heart Fail. 2021 Feb 15. doi: 10.1002/ejhf.2125.
    PubMed         Abstract available

  8. RICHARDS AM
    Cardiac Myosin-Binding Protein C as a candidate biomarker in Heart Failure: rational but not revolutionary.
    Eur J Heart Fail. 2021 Feb 15. doi: 10.1002/ejhf.2126.
    PubMed        

  9. BUTT JH, Nicolau JC, Verma S, Docherty KF, et al
    Efficacy and Safety of Dapagliflozin According to Aetiology in Heart Failure with Reduced Ejection Fraction: Insights from the DAPA-HF trial.
    Eur J Heart Fail. 2021 Feb 16. doi: 10.1002/ejhf.2124.
    PubMed         Abstract available

  10. BECHER PM, Schrage B, Ferrannini G, Benson L, et al
    Use of Sodium-Glucose Co-transporter 2 Inhibitors in Patients with Heart Failure and Type 2 Diabetes Mellitus: Data from the Swedish Heart Failure Registry.
    Eur J Heart Fail. 2021 Feb 18. doi: 10.1002/ejhf.2131.
    PubMed         Abstract available

  11. CHIONCEL O, Ambrosy AP, Maggioni AP
    Temporal Trends in the Outcomes of Acute Heart Failure: Between Consolatory Evidences and Real Progress.
    Eur J Heart Fail. 2021 Feb 18. doi: 10.1002/ejhf.2130.
    PubMed        

  12. LEBEK S, Tafelmeier M, Messmann R, Provaznik Z, et al
    Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease.
    Eur J Heart Fail. 2020;22:2248-2257.
    PubMed         Abstract available

  13. BOZKURT B, Coats A, Tsutsui H
    A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure Consensus Conference.
    Eur J Heart Fail. 2021 Feb 19. doi: 10.1002/ejhf.2115.
    PubMed        


    Heart

  14. CHEHAB O, Roberts-Thomson R, Ng Yin Ling C, Marber M, et al
    Secondary mitral regurgitation: pathophysiology, proportionality and prognosis.
    Heart. 2020 Feb 13. pii: heartjnl-2019-316238. doi: 10.1136/heartjnl-2019-316238
    PubMed         Abstract available


    Int J Cardiol

  15. WANG X, Li X
    Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia.
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00269.
    PubMed        

  16. PASSINO C, Sciarrone P, Vergaro G, Borrelli C, et al
    Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction.
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00263.
    PubMed         Abstract available

  17. SCALVINI S, Bernocchi P, Villa S, Paganoni AM, et al
    Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100,785 patients.
    Int J Cardiol. 2021 Feb 11. pii: S0167-5273(21)00267.
    PubMed         Abstract available

  18. HSIAO FC, Lin CP, Tung YC, Chang PC, et al
    Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional study.
    Int J Cardiol. 2021 Feb 12. pii: S0167-5273(21)00288.
    PubMed         Abstract available

  19. SAKANE K, Kanzaki Y, Hoshiga M
    Reply to "Clinical Significance of B-type Natriuretic Peptide in Patient with Acute Decompensated Heart Failure".
    Int J Cardiol. 2021 Feb 10. pii: S0167-5273(21)00272.
    PubMed        


    J Am Coll Cardiol

  20. GREENE SJ, Triana TS, Ionescu-Ittu R, Shi S, et al
    Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States.
    J Am Coll Cardiol. 2021;77:1023-1025.
    PubMed        


    J Card Fail

  21. IMAMURA T
    Implication of Cardiac Reverse Remodeling during Left Ventricular Assist Device Support in Women.
    J Card Fail. 2020;26:640.
    PubMed        

  22. SARSWAT N
    An Orphan Disease No More: Additional Treatment Options for Cardiac Amyloidosis.
    J Card Fail. 2020;26:760-761.
    PubMed        

  23. CABRERA CC
    Response to the Letter to the Editor by Drs. Izumida and Imamura.
    J Card Fail. 2020;26:809.
    PubMed        

  24. KENIGSBERG BB, Mohammed SF
    Response to Letter to the Editor from Imamura.
    J Card Fail. 2020;26:641.
    PubMed        

  25. ESPOSITO G, Schiattarella GG
    Feeding Diastolic Dysfunction: Is It a Bug?
    J Card Fail. 2020;26:703-704.
    PubMed        

  26. FORMAN DE, Peterson LR
    Cardiac Rehabilitation: You Can't Have "Too Much of a Good Thing".
    J Card Fail. 2020;26:652-653.
    PubMed        

  27. MANOURAS A, Lund LH
    Pulmonary hypertension and HFpEF: treating resistance, impedance, and compliance.
    J Card Fail. 2020 Jul 15. pii: S1071-9164(20)30860.
    PubMed        

  28. ALBERT NM
    Optimized Medical Therapies in Heart Failure with Reduced Ejection Fraction: It Takes Two to Tango.
    J Card Fail. 2021 Jan 5. pii: S1071-9164(21)00001.
    PubMed        

  29. KONSTAM MA
    The Journey Toward Advances in Diuretics Management: Quite Far and Not Far Enough.
    J Card Fail. 2020;26:802-805.
    PubMed        


    J Cardiol

  30. KIKUCHI A, Taniguchi T, Nakamoto K, Sera F, et al
    Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure: A pilot study.
    J Cardiol. 2021 Feb 10. pii: S0914-5087(21)00023.
    PubMed         Abstract available


    PLoS One

  31. DE MARIA B, Dalla Vecchia LA, Maestri R, Pinna GD, et al
    Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals.
    PLoS One. 2021;16:e0247145.
    PubMed         Abstract available

  32. FUNAMIZU T, Nagatomo Y, Saji M, Iguchi N, et al
    Low muscle mass assessed by psoas muscle area is associated with clinical adverse events in elderly patients with heart failure.
    PLoS One. 2021;16:e0247140.
    PubMed         Abstract available

  33. YOLA IM, Oh A, Mitchell GF, O'Connor G, et al
    Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
    PLoS One. 2021;16:e0246355.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: